Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback